参考文献/References:
[1] 惠立本,张 蕾.彩色多普勒超声检查诊断宫颈癌及其盆腔淋巴结转移临床价值分析[J].陕西医学杂志,2020,49(12):1624-1626.
[2] Matsuo K,Purushotham S,Moeini A,et al.A pilot study in using deep learning to predict limited life expectancy in women with recurrent cervical cancer[J].American Journal of Obstetrics & Gynecology,2017,217(6):703-705.
[3] Moeiui A,Ciccne MA.Efficacy of modified dose-dense paclitaxel in recurrent cervical cancer[J].American Journal of Clinical Oncology:Cancer Clinical Trials,2018,41(9):851-860.
[4] 周 齐,董友玲,刘宏伟,等.腹腔镜下卵巢移位术对宫颈癌放疗患者卵巢功能、性生活质量的影响[J].解放军预防医学杂志,2019,37(9):129-130,135.
[5] 冯文霄,刘晓红,刘 艳,等.腹腔镜根治性子宫切除术与开腹根治性子宫切除术治疗早期宫颈癌疗效的Meta分析[J].中国妇幼保健,2020,35(4):769-774.
[6] 唐 秋,屠晔强,陈建红,等.同步放化疗治疗早期宫颈癌术后中危患者的疗效分析[J].中华肿瘤杂志,2018,40(6):462-466.
[7] 胡 艳,常晓斌,王国庆,等.宫颈癌538例预后影响因素分析[J].陕西医学杂志,2017,46(11):1531-1534.
[8] Ercelep Z,Tatarolu D,Zelik M,et al.Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer[J].Journal of Turkish Society of Obstetric and Gynecology,2020,17(2):123-127.
[9] Cohen AC,Roane BM,Leath ICA.Novel therapeutics for recurrent cervical cancer:Moving towards personalized therapy[J].Drugs,2020,80(3):217-227.
[10] 李妞妞,郭广玲,王铁延.ⅠA-ⅡA期宫颈癌患者临床特征及术后复发影响因素分析[J].中国妇幼健康研究,2018,29(1):110-113.
[11] 袁 敏,王岩,古扎丽努尔?阿不力孜.早期宫颈腺癌临床病理特征及预后相关因素分析[J].中华肿瘤防治杂志,2019,26(14):64-68.
[12] 王 燕,舒月红,丁叔波,等.MR联合血清SSCA检测对宫颈癌患者疗效及预后预测分析[J].中华肿瘤防治杂志,2018,25(21):1522-1527.
[13] 蒋佳佳,刘 红,王玉净,等.宫颈癌术后盆腔复发患者放射治疗效果及预后的影响因素[J].中华放射医学与防护杂志,2019,39(3):208-212.
[14] 孙 畅,路 顺,张菡奕,等.肿瘤体积及瘤体缩减率在同步放化疗的宫颈癌患者预后中的价值[J].肿瘤预防与治疗,2019,32(5):421-428.
[15] 贺红英,阳志军,曾定元,等.腹腔镜与开腹手术治疗早期宫颈癌的疗效比较[J].中华肿瘤杂志,2017,39(6):458-466.
[16] 周 滢,姜继勇.早期宫颈癌淋巴脉管间隙浸润与临床病理因素及预后的关系[J].实用妇产科杂志,2018,34(3):203-207.
[17] 聂芳芳,陈小琴,付 杰.早期高危宫颈癌术后同期放化疗研究进展[J].中华放射肿瘤学杂志,2017,26(12):1470-1474.
[18] 温月凤,曾丽斯,黄文瑾,等.循环肿瘤细胞与Ⅰ-Ⅱ A期宫颈癌临床病理参数的相关性[J].肿瘤学杂志,2018,24(3):247-249.
[19] 廖丽川,孟以秀,向安玲,等.血浆循环肿瘤DNA与宫颈癌临床病理、疗效及预后的关系[J].川北医学院学报,2019,34(3):411-414.
[20] 李玲霞,李 佳,刘淑娟,等.宫颈癌患者外周血循环肿瘤细胞检测的意义[J].现代生物医学进展,2019,19(17):3285-3288,3305.
相似文献/References:
[1]梁 媛,蔡江义,谢 云,等.DNA倍体分析联合血清肿瘤标志物筛查宫颈癌价值研究[J].陕西医学杂志,2021,50(10):1296.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.031]
[2]王 静,袁 渊,周 敏,等.细胞周期蛋白依赖性激酶亚基2通过干预线粒体功能促进宫颈癌细胞增殖机制研究[J].陕西医学杂志,2022,51(2):136.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.002]
WANG Jing,YUAN Yuan,ZHOU Min,et al.CKS2 promotes the proliferation of cervical cancer cells by interfering with mitochondrial function[J].,2022,51(4):136.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.002]
[3]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(4):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
[4]马英桥,李建梅,孙静宜.外周血循环肿瘤细胞及血清催乳素、游离前列腺抗原与乳腺癌患者术后转移相关性研究[J].陕西医学杂志,2023,52(7):855.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.018]
MA Yingqiao,LI Jianmei,SUN Jingyi.Correlation between circulating tumor cells in peripheral blood,serum prolactin,free prostate antigen and postoperative metastasis of breast cancer[J].,2023,52(4):855.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.018]
[5]吕瑜玫,陈 丹,朱 桥,等.宫颈癌患者血清微小核糖核酸-381、微小核糖核酸-145水平变化及与临床病理参数相关性分析[J].陕西医学杂志,2023,52(7):925.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.034]
LYU Yumei,CHEN Dan,ZHU Qiao,et al.Changes of serum microRNA-381 and microRNA-145 levels and their correlation with clinicopathological parameters in patients with cervical cancer[J].,2023,52(4):925.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.034]
[6]袁浩鑫,冯一平,王思雨,等.调控miR-642a-5p表达对宫颈癌HeLa细胞生物学行为的影响及机制研究[J].陕西医学杂志,2023,52(11):1498.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.010]
YUAN Haoxin,FENG Yiping,WANG Siyu,et al.Effects and mechanism of regulating miR-642a-5p expression on biological behavior of cervical cancer HeLa cells[J].,2023,52(4):1498.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.010]
[7]常娟娟,李太平,康婉英,等.容积旋转调强与调强放疗在宫颈癌放疗中的应用及剂量学、安全性研究[J].陕西医学杂志,2024,(2):194.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.010]
CHANG Juanjuan,LI Taiping,KANG Wanying,et al.Application,dosimetric and safety analysis of volumetric modulated arc therapy and intensity modulated radiation therapy in radiotherapy of cervical cancer[J].,2024,(4):194.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.010]
[8]惠玉洁,朱林凤,李卫民,等.宫颈癌患者血清微小RNA-195、双皮质素样激酶1、鳞状细胞癌抗原表达水平与临床病理特征及预后相关性研究[J].陕西医学杂志,2024,(5):696.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.027]
HUI Yujie,ZHU Linfeng,LI Weimin,et al.Relationship between serum microRNA-195,doublecortin-like kinase 1,squamous cell carcinoma antigen levels and clinicopathological featuresand prognosis in patients with cervical cancer[J].,2024,(4):696.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.027]
[9]季 滢,郑艳莉,韩 云,等.尼美舒利对宫颈癌荷瘤裸鼠移植瘤的影响及机制实验研究[J].陕西医学杂志,2024,(8):1026.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.004]
JI Ying,ZHENG Yanli,HAN Yun,et al.Effect of nimesulide on cervical cancer tumor-bearing nude mice xenograft and its mechanism[J].,2024,(4):1026.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.004]
[10]冯敏娟,蔡东阁,李 虹.转录因子7-like 2在宫颈癌中表达水平及其与顺铂化疗敏感性关系研究[J].陕西医学杂志,2024,(10):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
FENG Minjuan,CAI Dongge,LI Hong.Expression level of transcription factor 7-like 2 in cervical cancer and its relationship with cisplatin chemotherapy sensitivity[J].,2024,(4):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]